Atara biotherapeutics announces changes to its board of directors

Thousand oaks, calif.--( business wire )--atara biotherapeutics, inc. (nasdaq: atra) today announced that carol gallagher will assume the role of chair of the board of directors, replacing ron renaud, who is stepping down to focus on his new position as managing director at bain capital life sciences.

ATRA Ratings Summary

ATRA Quant Ranking